Acute Stroke/transient Ischemic Attack Ticagrelor vs. ASS has no benefit in the TIA- or ACS- Secondary Prevention

被引：0
|
作者：
Lichert, Frank y
机构：
来源：
AKTUELLE KARDIOLOGIE | 2016年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [21] Seamless model of Secondary Stroke Prevention Self-Empowerment Program (SSPP) for transient ischemic attack (TIA) and minor stroke patients
    Tam, Y. M.
    Yu, C. T. M.
    Lam, S. W. S.
    Wong, S. K. E.
    Chen, W.
    Chan, M.
    Chan, W. Y. E.
    Lee, S. P. P.
    Cheung, K. Y.
    Ng, P. W.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 283 - 283
  • [22] Secondary Prevention Atrial Fibrillation is common for after stroke or Transient Ischaemic Attack (TIA)?
    Sposato, L. A.
    Cipriano, L. E.
    Saposnik, G.
    AKTUELLE NEUROLOGIE, 2015, 42 (09) : E116 - E116
  • [23] Occult vs. Known Atrial Fibrillation After Acute Ischemic Stroke and Transient Ischemic Attack: Are There Any Differences?
    Riccio, Patricia M.
    Klein, Francisco
    Jauregui, Agustin
    Ferrua, Marisol
    Zamora, Rafael
    Sposato, Luciano A.
    STROKE, 2010, 41 (04) : E216 - E216
  • [24] AS01 Acute Stroke Therapy, Management and Prehospital Care TIME COURSE FOR BENEFIT AND RISK OF TICAGRELOR AND ASPIRIN AFTER ACUTE ISCHEMIC STROKE AND TRANSIENT ISCHEMIC ATTACK: A SECONDARY ANALYSIS FROM THE THALES TRIAL
    Wang, Y.
    Pan, Y.
    Li, H.
    Amarenco, P.
    Denison, H.
    Evans, S. R.
    Himmelmann, A.
    James, S.
    Knutsson, M.
    Ladenvall, P.
    Molina, C. A.
    Johnston, S. C.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 24 - 24
  • [25] TRIAL OF SECONDARY PREVENTION WITH ATENOLOL AFTER TRANSIENT ISCHEMIC ATTACK OR NONDISABLING ISCHEMIC STROKE
    ALGRA, A
    VANGIJN, J
    KAPPELLE, LJ
    VANLATUM, JC
    KOUDSTAAL, PJ
    STROKE, 1993, 24 (04) : 543 - 548
  • [26] TIME COURSE FOR BENEFIT AND RISK OF TICAGRELOR AND ASPIRIN AFTER ACUTE STROKE AND TRANSIENT ISCHEMIC ATTACK: A SECONDARY ANALYSIS FROM THE CHANCE-2 RANDOMIZED TRIAL
    Pan, Y.
    Meng, X.
    Li, H.
    Wang, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 174 - 174
  • [27] Response by Wang and Johnston to Letter Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)"
    Wang, Yongjun
    Johnston, S. Claiborne
    STROKE, 2017, 48 (04) : e111 - e111
  • [28] Letter by Moris et al Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)"
    Moris, Demetrios
    Bakoyiannis, Chris
    Avgerinos, Efthymios
    STROKE, 2017, 48 (04) : e110 - e110
  • [29] Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack
    Huang, Hsin-Yi
    Chen, Jia-Hung
    Chi, Nai-Fang
    Chen, You-Chia
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (06) : 904 - 916
  • [30] Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
    Lin, Chun-Jen
    Tseng, Tzu-Yun
    Saver, Jeffrey L.
    FRONTIERS IN NEUROLOGY, 2022, 13
12345